Drug ID: | NPD1696 |
Drug Name: | Irofulven |
Molecular Formula: | C15H18O3 |
Canonical SMILES: | OCC1=C(C)C=C2C1=C(C)C1([C@@](C2=O)(C)O)CC1 |
Standard InCHI: | InChI=1S/C15H18O3/c1-8-6-10-12(11(8)7-16)9(2)15(4-5-15)14(3,18)13(10)17/h6,16,18H,4-5,7H2,1-3H3/t14-/m0/s1 |
Standard InCHIKey: | NICJCIQSJJKZAH-AWEZNQCLSA-N |
Max Developmental Stage: | Phase 3 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002729 |
DrugBank | DB05786 |
ChEMBL | CHEMBL118218 |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 148189 |
ChEBI | 135002 |
CAS Number | 158440-71-2 |
Molecular Weight | 246.13 |
ALogP | 0.4462 |
MLogP | 2.78 |
XLogP | 0.062 |
HDA | 3 |
HBD | 2 |
Rotatable Bonds | 6 |
TPSA | 57.53 |
RO5 Violation | 0 |